Merck KGaA (OTCMKTS:MKGAF – Get Free Report)’s share price traded up 9% on Wednesday . The company traded as high as $162.76 and last traded at $162.76. 3 shares were traded during mid-day trading, a decline of 100% from the average daily volume of 663 shares. The stock had previously closed at $149.2780.
Merck KGaA Stock Performance
The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The stock has a market cap of $20.86 billion, a price-to-earnings ratio of 24.64 and a beta of 0.96. The firm’s 50-day moving average is $146.70 and its two-hundred day moving average is $143.72.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
See Also
- Five stocks we like better than Merck KGaA
- BlackBerry’s Rally Is Running on a Bigger AI Story Than Earnings Alone
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
